إعلان
إعلان
NRIX
Nurix Therapeutics, Inc. Common stock
19.30
USDبرعاية
+0.66
+3.56%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
19.33
+0.03
+0.16%
تقارير أرباح NRIX
النسبة الإيجابية المفاجئة
NRIX تفوق 9 من 21 آخر التقديرات.
43%
التقرير التالي
بيانات التقرير القادم
٢٦ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$14.60M
/-$0.90
التغير الضمني من Q3 25 (Revenue/ EPS)
+84.89%
/-12.62%
التغير الضمني من Q4 24 (Revenue/ EPS)
+9.87%
/+20.00%
Nurix Therapeutics, Inc. Common stock earnings per share and revenue
On ٠٩ أكتوبر ٢٠٢٥, NRIX reported earnings of -1.03 USD per share (EPS) for Q3 25, missing the estimate of -0.85 USD, resulting in a -20.05% surprise. Revenue reached 7.89 مليون, compared to an expected 17.07 مليون, with a -53.76% difference. The market reacted with a -10.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 المحللين forecast an EPS of -0.90 USD, with revenue projected to reach 14.60 مليون USD, implying an نقصان of -12.62% EPS, and زيادة of 84.89% in Revenue from the last quarter.
الأسئلة الشائعة
What were Nurix Therapeutics, Inc. Common stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nurix Therapeutics, Inc. Common stock reported EPS of -$1.03, missing estimates by -20.05%, and revenue of $7.89M, -53.76% below expectations.
How did the market react to Nurix Therapeutics, Inc. Common stock's Q3 2025 earnings?
The stock price moved down -10.13%, changed from $10.86 before the earnings release to $9.76 the day after.
When is Nurix Therapeutics, Inc. Common stock expected to report next?
The next earning report is scheduled for ٢٦ يناير ٢٠٢٦.
What are the forecasts for Nurix Therapeutics, Inc. Common stock's next earnings report?
Based on 19
المحللين, Nurix Therapeutics, Inc. Common stock is expected to report EPS of -$0.90 and revenue of $14.60M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان